IBM €3.75 billion notes offering
Davis Polk advised the underwriters in connection with a public offering by International Business Machines Corporation of €1.3 billion principal amount of its 0.300% notes due 2028, €1.6…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
RAPT Therapeutics $75 million follow-on offering
Davis Polk advised the underwriters in connection with a $75 million public offering of common stock by RAPT Therapeutics, Inc. RAPT Therapeutics’ common stock is listed on the …
SMART Global Holdings $250 million convertible senior notes offering
Davis Polk advised SMART Global Holdings, Inc. in connection with a Rule 144A offering of $250 million aggregate principal amount of its 2.25% convertible senior notes due 2026. Davis Polk…
Uniti $2.25 billion senior secured notes offering and credit agreement amendment
Davis Polk advised Uniti Group Inc. in connection with a Rule 144A and Regulation S offering of $2.25 billion aggregate principal amount of 7.875% senior secured notes due 2025 issued by…
Beam Therapeutics $180 million IPO
Davis Polk advised the joint book-running managers in connection with the $180 million initial public offering of common stock of Beam Therapeutics Inc. The common stock is listed on the…
Clarivate Analytics $559 million share offering
Davis Polk advised Clarivate Analytics Plc in connection with the $559 million SEC-registered offering of 27,600,000 of its ordinary shares. The ordinary shares are listed on the New York…
Stanley Black & Decker $1.5 billion offering of senior and subordinated debt
Davis Polk advised the joint book-running managers and representatives of the underwriters on an SEC-registered offering by Stanley Black & Decker, Inc. of $750 million aggregate…
TriState Capital Holdings $59.9 million secondary offering
Davis Polk advised the underwriter in connection with the $59.9 million secondary offering of 2,678,049 shares of common stock of TriState Capital Holdings, Inc. by selling shareholders LM…
Credivalores $300 million high-yield notes offering and tender offer
Davis Polk advised the initial purchasers on a Rule 144A and Regulation S offering of $300 million aggregate principal amount of 8.875% senior notes due 2025 of Credivalores–Crediservicios…
Integra LifeSciences Holdings $575 million convertible senior notes offering
Davis Polk advised the joint book-running managers and representatives of the initial purchasers on a Rule 144A offering by Integra LifeSciences Holdings Corporation of $575 million…